Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. (Q52932701)
Jump to navigation
Jump to search
scientific article published in June 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. |
scientific article published in June 2006 |
Statements
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. (English)
Corinna Leng
Margarethe Gries
Judy Ziegler
Anna Lokshin
Paolo Mascagni
Suzanne Lentzsch
Markus Y Mapara
1 June 2006
34
6
776-787